Loading your page…
Each register with its number of medicines and a few of them.
Health Canada · 4 medicines · Historical list
FDA · 2 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
6 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Suvorexant | United States | 10MG, 15MG, 20MG … | tablet | Tentative approval | Hetero Labs LTD Unit III |
| Belsomra | United States | 10MG, 15MG, 20MG … | tablet | Marketed | Merck Sharp Dohme |
| Belsomra | Canada | 15 MG | Tablet | Cancelled | Merck Canada INC |
| Belsomra | Canada | 10 MG | Tablet | Cancelled | Merck Canada INC |
| Belsomra | Canada | 5 MG | Tablet | Cancelled | Merck Canada INC |
| Belsomra | Canada | 20 MG | Tablet | Cancelled | Merck Canada INC |
The same brand on several registers.
The companies holding its medicines, the most first.
Compiled by Prognia from the public medicine registers of FDA and Health Canada. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
